Skip to content

A multi-centric trial of front-loaded smear microscopy in the diagnosis of tuberculosis

A multi-centric trial of front-loaded smear microscopy in the diagnosis of tuberculosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN53339491
Enrollment
6852
Registered
2008-04-08
Start date
2008-01-06
Completion date
Unknown
Last updated
2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis Infections and Infestations Tuberculosis

Interventions

Scheme one: experimental arm - Each patient attending during this week will be requested to provide: 1. One on-the-spot sputum sample at the time of the patient's first visit 2. A second on-the-spot

Sponsors

Liverpool School of Tropical Medicine (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Symptoms suggesting pulmonary TB: persistent cough (generally greater than two weeks) 2. Provision of informed consent to participation 3. Age greater than 18 years old, either sex

Exclusion criteria

Exclusion criteria: 1. Inability to provide informed consent (e.g., unfamiliarity with language of patient information/consent forms, prisoners, mentally impaired) 2. Anti-tuberculous treatment in the last month

Design outcomes

Secondary

MeasureTime frame
1. Sensitivity, specificity, positive and negative predictive value of: 1.1. A single positive smear 1.2. A single positive smear considering smears with scanty acid-fast bacilli (AFB) as positive 1.3. The smears collected as spot, extra-spot and morning or spot-morning-spot 2. Proportion of patients with positive culture identified by two smears prepared from a single specimens 3. The incremental yield of the second and third samples

Primary

MeasureTime frame
These outcomes will be established for each diagnostic strategy and will use culture as gold standard: 1. Sensitivity, specificity, positive and negative predictive value of smear microscopy when using: 1.1. The WHO case definitions for smear-positive tuberculosis 1.2. The first two specimens collected by each strategy (spot and extra-spot versus spot and morning) 2. The number of patients referred to a TB treatment centre 24, 48 and 72 hours after their initial consultation 3. The number of patients who drop out of the diagnostic process

Countries

Brazil, Ethiopia, Nepal, Nigeria, Yemen

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 28, 2026